ArticleCancer medicine2024

Toripalimab plus chemotherapy in American patients with recurrent or metastatic nasopharyngeal carcinoma: A cost-effectiveness analysis.

Dai Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.